In obesity, low-grade chronic inflammation, adipocyte dysfunction and metabolic abnormalities alter the breast tumour microenvironment and upregulate expression of aromatase [14] to exacerbate risk for breast cancer incidence and progression. Here, CYP19A1 is linked to breast cancer.